Guidance and Visibility Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility

AAPL 270.98

-0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ChrisJP who wrote (54230)	5/30/2002 9:06:39 AM
From: SusieQ1065	Read Replies (1) of 208838

09:01 ET DNA Genentech: cautious comments by JP Morgan (36.55) JP Morgan says that the co's near-term pipeline risk is not adequately reflected by the premium valuation; firm believes there is a significant amount of risk associated with the pending results of a Phase III trial of Avastin in patients with metastatic breast cancer, and if the results are not strong enough to warrant a regulatory filing for Avastin this year, the co may experience a significant deceleration in top line growth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next